Maarten Laroy , Filip Bouckaert , Olga Therese Ousdal , Annemieke Dols , Didi Rhebergen , Eric van Exel , Guido van Wingen , Jeroen van Waarde , Joey Verdijk , Ute Kessler , Hauke Bartsch , Martin Balslev Jorgensen , Olaf B. Paulson , Pia Nordanskog , Joan Prudic , Pascal Sienaert , Mathieu Vandenbulcke , Leif Oltedal , Louise Emsell , for GEMRIC
{"title":"Characterization of gray matter volume changes from one week to 6 months after termination of electroconvulsive therapy in depressed patients","authors":"Maarten Laroy , Filip Bouckaert , Olga Therese Ousdal , Annemieke Dols , Didi Rhebergen , Eric van Exel , Guido van Wingen , Jeroen van Waarde , Joey Verdijk , Ute Kessler , Hauke Bartsch , Martin Balslev Jorgensen , Olaf B. Paulson , Pia Nordanskog , Joan Prudic , Pascal Sienaert , Mathieu Vandenbulcke , Leif Oltedal , Louise Emsell , for GEMRIC","doi":"10.1016/j.brs.2024.07.015","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Increased gray matter volume (GMV) following electroconvulsive therapy (ECT) has been well-documented, with limited studies reporting a subsequent decrease in GMV afterwards.</p></div><div><h3>Objective</h3><p>This study characterized the reversion pattern of GMV after ECT and its association with clinical depression outcome, using multi-site triple time-point data from the Global ECT-MRI Research Collaboration (GEMRIC).</p></div><div><h3>Methods</h3><p>86 subjects from the GEMRIC database were included, and GMV in 84 regions-of-interest (ROI) was obtained from automatic segmentation of T1 MRI images at three timepoints: pre-ECT (<span><math><mrow><msub><mi>T</mi><mn>0</mn></msub></mrow></math></span>), within one-week post-ECT (<span><math><mrow><msub><mi>T</mi><mn>1</mn></msub></mrow></math></span>), and one to six months post-ECT (<span><math><mrow><msub><mi>T</mi><mn>2</mn></msub></mrow></math></span>). RM-ANOVAs were used to assess longitudinal changes and LMM analyses explored associations between GMV changes and demographical and clinical characteristics.</p></div><div><h3>Results</h3><p>63 of the 84 ROIs showed a significant increase-and-decrease pattern (RM-ANOVA, Bonferroni corrected p < 0.00059). Post hoc tests indicated a consistent pattern in each of these 63 ROIs: significant increase from <span><math><mrow><msub><mi>T</mi><mn>0</mn></msub></mrow></math></span> to <span><math><mrow><msub><mi>T</mi><mn>1</mn></msub><mtext>in</mtext><mspace></mspace><mtext>GMV</mtext></mrow></math></span>, followed by significant decrease from <span><math><mrow><msub><mi>T</mi><mn>1</mn></msub></mrow></math></span> to <span><math><mrow><msub><mi>T</mi><mn>2</mn></msub></mrow></math></span> and no difference between <span><math><mrow><msub><mi>T</mi><mn>0</mn></msub></mrow></math></span> and <span><math><mrow><msub><mi>T</mi><mn>2</mn></msub></mrow></math></span>, except for both amygdalae, right hippocampus and pars triangularis, which showed the same increase and decrease but GMV at <span><math><mrow><msub><mi>T</mi><mn>2</mn></msub></mrow></math></span> remained higher compared to <span><math><mrow><msub><mi>T</mi><mn>0</mn></msub></mrow></math></span>. No consistent relationship was found between GMV change pattern and clinical status.</p></div><div><h3>Conclusion</h3><p>The GEMRIC cohort confirmed a rapid increase of GMV after ECT followed by reversion of GMV one to six months thereafter. The lack of association between the GMV change pattern and depression outcome scores implies a transient neurobiological effect of ECT unrelated to clinical improvement.</p></div>","PeriodicalId":9206,"journal":{"name":"Brain Stimulation","volume":"17 4","pages":"Pages 876-886"},"PeriodicalIF":7.6000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1935861X24001281/pdfft?md5=42bdce731955d42bde6e214f0afb2189&pid=1-s2.0-S1935861X24001281-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain Stimulation","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1935861X24001281","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Increased gray matter volume (GMV) following electroconvulsive therapy (ECT) has been well-documented, with limited studies reporting a subsequent decrease in GMV afterwards.
Objective
This study characterized the reversion pattern of GMV after ECT and its association with clinical depression outcome, using multi-site triple time-point data from the Global ECT-MRI Research Collaboration (GEMRIC).
Methods
86 subjects from the GEMRIC database were included, and GMV in 84 regions-of-interest (ROI) was obtained from automatic segmentation of T1 MRI images at three timepoints: pre-ECT (), within one-week post-ECT (), and one to six months post-ECT (). RM-ANOVAs were used to assess longitudinal changes and LMM analyses explored associations between GMV changes and demographical and clinical characteristics.
Results
63 of the 84 ROIs showed a significant increase-and-decrease pattern (RM-ANOVA, Bonferroni corrected p < 0.00059). Post hoc tests indicated a consistent pattern in each of these 63 ROIs: significant increase from to , followed by significant decrease from to and no difference between and , except for both amygdalae, right hippocampus and pars triangularis, which showed the same increase and decrease but GMV at remained higher compared to . No consistent relationship was found between GMV change pattern and clinical status.
Conclusion
The GEMRIC cohort confirmed a rapid increase of GMV after ECT followed by reversion of GMV one to six months thereafter. The lack of association between the GMV change pattern and depression outcome scores implies a transient neurobiological effect of ECT unrelated to clinical improvement.
期刊介绍:
Brain Stimulation publishes on the entire field of brain stimulation, including noninvasive and invasive techniques and technologies that alter brain function through the use of electrical, magnetic, radiowave, or focally targeted pharmacologic stimulation.
Brain Stimulation aims to be the premier journal for publication of original research in the field of neuromodulation. The journal includes: a) Original articles; b) Short Communications; c) Invited and original reviews; d) Technology and methodological perspectives (reviews of new devices, description of new methods, etc.); and e) Letters to the Editor. Special issues of the journal will be considered based on scientific merit.